SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-013395
Filing Date
2020-05-18
Accepted
2020-05-18 16:45:20
Documents
1
Period of Report
2020-05-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6305
  Complete submission text file 0000899243-20-013395.txt   8118
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 400 OYSTER BLVD. SUITE 202 SOUTH SAN FRANCISCO CA 94080
Business Address 400 OYSTER BLVD. SUITE 202 SOUTH SAN FRANCISCO CA 94080 (650) 745-8179
VELOCITY PHARMACEUTICAL HOLDINGS LLC (Reporting) CIK: 0001802702 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-32587 | Film No.: 20890271